Sikiric et al., 2020b), even those with large part of the bowel removal (Sever et al., 2009
Soth MJ, Le K, Di Francesco ME, Hamilton MM,Liu G, Burke JP,Carroll CL,Kovacs JJ, Bardenhagen JP,Bristow CA,Cardozo M, Czako B, de Stanchina E, Feng N, Garvey JR, Gay JP,Do MKG, Greer J, Han MHA, Herrera Z,Huang S
Dox pretreatment alone delayed the onset of ferroptosis (i.e., increased D O ) in response to erastin2 in Control cells capable of expressing p21, albeit not to the same extent as nutlin-3 treatment (Fig 2B and C)
among these approaches is N-to-B delivery which is becoming of great interest as an alternative to usual administration routes [4,6,7,8,11,13,14]
Without biomarker context, supplementation may represent unnecessary expense and potential metabolic interference rather than targeted intervention